Quarterly Result30 Jul 2025, 06:15 pm
JB Pharma Reports 9% Revenue Growth to INR 1094 Crores in Q1 FY26
AI Summary
JB Chemicals & Pharmaceuticals Ltd (JB Pharma) announced its financial results for the quarter ended 30th June 2025. The company recorded revenue of INR 1,094 crores, representing a 9% growth from INR 1,004 crores in Q1 FY25. Operating EBITDA increased by 13% to INR 330 crores, and net profit rose by 14% to INR 202 crores.
Key Highlights
- Revenue growth of 9% to INR 1094 crores
- Operating EBITDA increased by 13% to INR 330 crores
- Net profit increases by 14% to INR 202 crores
- Domestic business recorded approx. 14% value growth
- Operating EBITDA* margins crossed 30% for the first time